Immunomodulatory Properties of Natural Extracts and Compounds Derived from Bidens pilosa L.: Literature Review

Author:

Rodríguez-Mesa Xandy Melissa1ORCID,Contreras Bolaños Leonardo Andres1,Mejía Antonio12ORCID,Pombo Luis Miguel2ORCID,Modesti Costa Geison3ORCID,Santander González Sandra Paola1ORCID

Affiliation:

1. Phytoimmunomodulation Research Group, Juan N. Corpas University Foundation, Bogotá Carrera 111 #159A-61, Bogota 111321, Colombia

2. Plant Pharmacology and Alternative Therapeutics, Juan N. Corpas University Foundation, Bogotá Carrera 111 #159A-61, Bogota 111321, Colombia

3. Phytochemistry Research Group (GIFUJ), Pontificia Universidad Javeriana, Bogotá Carrera 7 #40-62, Bogota 110231, Colombia

Abstract

Bidens pilosa L. has been used in different parts of the world mainly to treat diseases associated with immune response disorders, such as autoimmunity, cancer, allergies, and infectious diseases. The medicinal properties of this plant are attributed to its chemical components. Nevertheless, there is little conclusive evidence that describes the immunomodulatory activity of this plant. In this review, a systematic search was carried out in the PubMed-NLM, EBSCO Host and BVS databases focused on the pre-clinical scientific evidence of the immunomodulatory properties of B. pilosa. A total of 314 articles were found and only 23 were selected. The results show that the compounds or extracts of Bidens modulate the immune cells. This activity was associated with the presence of phenolic compounds and flavonoids that control proliferation, oxidative stress, phagocytosis, and the production of cytokines of different cells. Most of the scientific information analyzed in this paper supports the potential use of B. pilosa mainly as an anti-inflammatory, antioxidant, antitumoral, antidiabetic, and antimicrobial immune response modulator. It is necessary that this biological activity be corroborated through the design of specialized clinical trials that demonstrate the effectiveness in the treatment of autoimmune diseases, chronic inflammation, and infectious diseases. Until now there has only been one clinical trial in phase I and II associated with the anti-inflammatory activity of Bidens in mucositis.

Publisher

MDPI AG

Subject

Pharmaceutical Science

Reference125 articles.

1. Bidens pilosa L.: Agricultural and pharmaceutical importance;Arthur;J. Med. Plants Res.,2012

2. Bidens pilosa L. (Asteraceae): Botanical Properties, Traditional Uses, Phytochemistry, and Pharmacology;Bartolome;Evid.-Based Complement. Altern. Med. ECAM,2013

3. Bidens pilosa L. (Asteraceae): Traditional use in a community of southern Brazil;Borges;Rev. Bras. Plantas Med.,2013

4. MU/Chipaca (2021, April 27). Muysc Cubun—Lengua Muisca. Available online: http://muysca.cubun.org/MU/chipaca.

5. Compilation of secondary metabolites from Bidens pilosa L;Silva;Molecules,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3